ipl512,602
Small moleculeexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00330070)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ipl512,602
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00330070 | Phase 2 | May 1, 2006 | Allergy Research Foundatin, Inc., Clinical Research Institute of Southern Oregon, Inflazyme Pharmaceuticals Ltd, University of Wisconsin, WCCT Global |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allergy Research Foundatin, Inc. | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Clinical Research Institute of Southern Oregon | For profit | 1 | 0 | 1 | 2006 |
| Inflazyme Pharmaceuticals Ltd | For profit | 1 | 1 | 1 | 2006 |
| University of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2006 |
| WCCT Global | For profit | 1 | 0 | 1 | 2006 |
5 organizations
Page 1 / 1